Nature vs. Nurture: Defining the Effects of Mesenchymal Stromal Cell Isolation and Culture Conditions on Resiliency to Palmitate Challenge

被引:16
作者
Boland, Lauren K. [1 ,2 ]
Burand, Anthony J. [1 ,2 ]
Boyt, Devlin T. [1 ,2 ]
Dobroski, Hannah [1 ,2 ]
Di, Lin [1 ,2 ]
Liszewski, Jesse N. [1 ,2 ]
Schrodt, Michael, V [1 ,2 ]
Frazer, Maria K. [1 ,2 ]
Santillan, Donna A. [3 ]
Ankrum, James A. [1 ,2 ]
机构
[1] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Iowa City, IA 52242 USA
[2] Univ Iowa, Roy J Carver Dept Biomed Engn, Iowa City, IA 52242 USA
[3] Univ Iowa, Dept Obstet & Gynecol, Ctr Immunol & Immune Based Dis, Ctr Hypertens Res, Iowa City, IA USA
来源
FRONTIERS IN IMMUNOLOGY | 2019年 / 10卷
基金
美国国家卫生研究院;
关键词
mesenchymal stromal cells; umbilical cord mesenchymal stromal cells; obesity; palmitate; human platelet lysate; fetal bovine serum; culture media; cell therapy; CLINICAL-SCALE EXPANSION; TYPE-2; DIABETIC-PATIENTS; STEM-CELLS; FATTY-ACIDS; SERUM; OBESITY; MSC; OPTIMIZATION; AUTOPHAGY; FEATURES;
D O I
10.3389/fimmu.2019.01080
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
As MSC products move from early development to clinical translation, culture conditions shift from xeno- to xeno-free systems. However, the impact of isolation and culture-expansion methods on the long-term resiliency of MSCs within challenging transplant environments is not fully understood. Recent work in our lab has shown that palmitate, a saturated fatty acid elevated in the serum of patients with obesity, causes MSCs to convert from an immunosuppressive to an immunostimulatory state at moderate to high physiological levels. This demonstrated that metabolically-diseased environments, like obesity, after the immunomodulatory efficacy of healthy donor MSCs. In addition, it highlighted the need to test MSC efficacy not only in ideal conditions, but within challenging metabolic environments. To determine how the choice of xeno- vs. xeno-free media during isolation and expansion would affect future immunosuppressive function, umbilical cord explants from seven donors were subdivided and cultured within xeno- (fetal bovine serum, FBS) or xeno-free (human platelet lysate, PLT) medias, creating 14 distinct MSC preparations. After isolation and primary expansion, umbilical cord MSCs (ucMSC) were evaluated according to the ISCT minimal criteria for MSCs. Following baseline characterization, ucMSC were exposed to physiological doses of palmitate and analyzed for metabolic health, apoptotic induction, and immunomodulatory potency in co-cultures with stimulated human peripheral blood mononuclear cells. The paired experimental design (each ucMSC donor grown in two distinct culture environments) allowed us to delineate the contribution of inherent (nature) vs. environmentally-driven (nurture) donor characteristics to the phenotypic response of ucMSC during palmitate exposure. Culturing MSCs in PLT-media led to more consistent growth characteristics during the isolation and expansion for all donors, resulting in faster doubling times and higher cell yields compared to FBS. Upon palmitate challenge, PLT-ucMSCs showed a higher susceptibility to palmitate-induced metabolic disturbance, but less susceptibility to palmitate-induced apoptosis. Most striking however, was that the PLT-ucMSCs resisted the conversion to an immunostimulatory phenotype better than their FBS counterparts. Interestingly, examining MSC suppression of PBMC proliferation at physiologic doses of palmitate magnified the differences between donors, highlighting the utility of evaluating MSC products in stress-based assays that reflect the challenges MSCs may encounter post-transplantation.
引用
收藏
页数:15
相关论文
共 73 条
  • [1] Adipose Mesenchymal Stromal Cells Isolated From Type 2 Diabetic Patients Display Reduced Fibrinolytic Activity
    Acosta, Lourdes
    Hmadcha, Abdelkrim
    Escacena, Natalia
    Perez-Camacho, Inmaculada
    de la Cuesta, Antonio
    Ruiz-Salmeron, Rafael
    Gauthier, Benoit R.
    Soria, Bernat
    [J]. DIABETES, 2013, 62 (12) : 4266 - 4269
  • [2] Obesity-driven disruption of haematopoiesis and the bone marrow niche
    Adler, Benjamin J.
    Kaushansky, Kenneth
    Rubin, Clinton T.
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2014, 10 (12) : 737 - 748
  • [3] Mesenchymal stem cell therapy: Two steps forward, one step back
    Ankrum, James
    Karp, Jeffrey M.
    [J]. TRENDS IN MOLECULAR MEDICINE, 2010, 16 (05) : 203 - 209
  • [4] Performance-enhanced mesenchymal stem cells via intracellular delivery of steroids
    Ankrum, James A.
    Dastidar, Riddhi G.
    Ong, Joon Faii
    Levy, Oren
    Karp, Jeffrey M.
    [J]. SCIENTIFIC REPORTS, 2014, 4
  • [5] Human platelet lysate in mesenchymal stromal cell expansion according to a GMP grade protocol: a cell factory experience
    Becherucci, Valentina
    Piccini, Luisa
    Casamassima, Serena
    Bisin, Silvia
    Gori, Valentina
    Gentile, Francesca
    Ceccantini, Riccardo
    De Rienzo, Elena
    Bindi, Barbara
    Pavan, Paola
    Cunial, Vanessa
    Allegro, Elisa
    Ermini, Stefano
    Brugnolo, Francesca
    Astori, Giuseppe
    Bambi, Franco
    [J]. STEM CELL RESEARCH & THERAPY, 2018, 9
  • [6] Human mesenchymal stem cells maintain their phenotype, multipotentiality, and genetic stability when cultured using a defined xeno-free human plasma fraction
    Blazquez-Prunera, Arantxa
    Diez, Jose Maria
    Gajardo, Rodrigo
    Grancha, Salvador
    [J]. STEM CELL RESEARCH & THERAPY, 2017, 8
  • [7] In Vivo Therapeutic Potential of Mesenchymal Stromal Cells Depends on the Source and the Isolation Procedure
    Bortolotti, Francesca
    Ukovich, Laura
    Razban, Vahid
    Martinelli, Valentina
    Ruozi, Giulia
    Pelos, Barbara
    Dore, Franca
    Giacca, Mauro
    Zacchigna, Serena
    [J]. STEM CELL REPORTS, 2015, 4 (03): : 332 - 339
  • [8] Changes in autophagy, proteasome activity and metabolism to determine a specific signature for acute and chronic senescent mesenchymal stromal cells
    Capasso, Stefania
    Alessio, Nicola
    Squillaro, Tiziana
    Di Bernardo, Giovanni
    Melone, Mariarosa A.
    Cipollaro, Marilena
    Peluso, Gianfranco
    Galderisi, Umberto
    [J]. ONCOTARGET, 2015, 6 (37) : 39457 - 39468
  • [9] PDGF Restores the Defective Phenotype of Adipose-Derived Mesenchymal Stromal Cells from Diabetic Patients
    Capilla-Gonzalez, Vivian
    Lopez-Beas, Javier
    Escacena, Natalia
    Aguilera, Yolanda
    de la Cuesta, Antonio
    Ruiz-Salmeron, Rafael
    Martin, Franz
    Hmadcha, Abdelkrim
    Soria, Bernat
    [J]. MOLECULAR THERAPY, 2018, 26 (11) : 2696 - 2709
  • [10] Proteome analysis of human amniotic mesenchymal stem cells (hA-MSCs) reveals impaired antioxidant ability, cytoskeleton and metabolic functionality in maternal obesity
    Capobianco, Valentina
    Caterino, Marianna
    Iaffaldano, Laura
    Nardelli, Carmela
    Sirico, Angelo
    Del Vecchio, Luigi
    Martinelli, Pasquale
    Pastore, Lucio
    Pucci, Pietro
    Sacchetti, Lucia
    [J]. SCIENTIFIC REPORTS, 2016, 6